Sun-Organon buyout shows Indian Pharma’s big hunger for overseas M&As — Here’s a list of other major deals

Indian drug companies are seeking overseas growth through acquisitions to diversify beyond generics amid global challenges. Here are some other big pharma deals over the past few months.